semaglutide court case update South Africa's High has granted Novo Nordisk an interim interdict barring a local pharmacy group from manufacturing and selling compounded weight-loss medicines containing semaglutide, in a ruling that shows tightening scrutiny Drug compounders sue FDA over

Candidates for Semaglutide (Wegovy) Failed Attempts to Lose Body Weight Many candidates for semaglutide have tried but not succeeded in losing weight through diet, exercise, and/or other anti-obesity medications

For a comprehensive overview of the current regulatory environment, read our are research peptides legal in 2026 guide and our FDA peptide reclassification 2026 update

J Nanobiotechnol 20:69 Meng H-M, Hu X-X, Kong G-Z, Yang C, Fu T, Li Z-H et al (2018) Aptamer-functionalized nanoscale metal-organic frameworks for targeted photodynamic therapy

Compounded prescription: Prepared by a licensed 503A compounding pharmacy pursuant to a valid prescription from a licensed prescriber

However, this question is controversial in humans [19-21]